SYROS PHARMACEUTICALS: “blocking of a few master genetic switches associated with “super enhancers” might be a simple cure for cancer, says Dr. Richard Young, of Whitehead research institute” and founder of Syros. They raised $83.1 M in two rounds,
https://lnkd.in/eSdUNqN
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022